Printer Friendly
The Free Library
14,694,313 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Antipsychotics and brain changes.


The use of antipsychotic drugs, rather than the action of a distinct disease process, appears to bloat the volume of several innerbrain regions in people diagnosed with schizophrenia, according to a team of neuroscientists.

The researchers, led by Raquel E. Gur of the University of Pennsylvania (body, education) University of Pennsylvania - The home of ENIAC and Machiavelli.

http://upenn.edu/.

Address: Philadelphia, PA, USA.
 Medical Center in Philadelphia, administered magnetic resonance imaging magnetic resonance imaging (MRI), noninvasive diagnostic technique that uses nuclear magnetic resonance to produce cross-sectional images of organs and other internal body structures.  (MRI) scans to 96 psychiatric patients with schizophrenia--a severe disturbance of thought and mood--and 128 people who had no psychiatric ailments. Of the patients, 21 had never taken antipsychotic medication, 48 had received only haloperidol haloperidol /hal·o·peri·dol/ (hal?o-per´i-dol) an antipsychotic agent of the butyrophenone group with antiemetic, hypotensive, and hypothermic actions; used especially in the management of psychoses and to control vocal utterances and  or other traditional antipsychotics for about 3 years, and 27 had used both traditional and newer medications, such as clozapine, over a similar period.

The volume of the basal ganglia was markedly greater in medication-treated patients than in both drug-free patients and healthy volunteers, the scientists report in the December AMERICAN JOURNAL OF PSYCHIATRY The American Journal of Psychiatry (AJP) is the most widely read psychiatric journal in the world. It covers topics on biological psychiatry, treatment innovations, forensic, ethical, economic, and social issues. . The basal ganglia consist of clumps of tissue involved in the regulation of movement and thinking. They showed the greatest volume in patients who had taken high doses of traditional antipsychotic drugs.

Medication-free patients differed from healthy volunteers only by having a smaller thalamus thalamus (thăl`əməs), mass of nerve cells centrally located in the brain just below the cerebrum and resembling a large egg in size and shape. , Gur and her coworkers say. Disturbances in this structure, which helps to focus attention and filter sensations, have already been implicated in schizophrenia (SN: 10/29/94, p. 284). -- B.B.
COPYRIGHT 1998 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1998, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:bloated basal ganglia associated with schizophrenia
Author:B.B.
Publication:Science News
Article Type:Brief Article
Date:Dec 19, 1998
Words:218
Previous Article:Stressful aftermath of early losses.(childhood trauma tied to adulthood hypertension)(Brief Article)
Next Article:Exhibit of fossils strains the definition of art.('Fossil Art' exhibit at Yale University's Peabody Museum of Natural History )
Topics:



Related Articles
Gene variety and psychiatric drugs. (Brief Article)
Schizophrenia: promising drug ... and infectious clues. (antipsychotic drug risperidone and impact of influenza in pregnant women on fetal brain...
Schizophrenia: data point to early roots. (three different studies indicate that schizophrenia may be linked to prenatal or early-age brain...
Memory's neural hit in schizophrenia.(memory deficits linked to schizophrenia)(Brief Article)
Untreated schizophrenia may spare brain.(Brief Article)
Dose of caution: new antipsychotic meds produce muted benefits. (Science News This Week).(Brief Article)
Schizophrenia syncs fast: disconnected brain may lie at heart of disorder.(This Week)
Metabolic issues in patients with severe mental illness.(risk factors of mental disorders)
Meds alert: old schizophrenia drug stands up to new ones.
Managing the risk of tardive dyskinesia: based on an interview with William M. Glazer, MD.(SPECIAL SECTION)(Interview)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles